Actinium Pharmaceuticals, Inc. (NYSE:ATNM)
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) represented a move of -3.5 percent or $0.02 per share and closed its previous day trading session at $0.58. 1.62 Million Shares were traded in the last trading session with an Average Volume of 975.16 Million Shares. The stock currently has a Market Capitalization of 64.47 Million.
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It specializes in the development of cancer drugs. The company’s principal product candidates under different developmental stages include Actimab-A for the treatment of acute myeloid leukemia in elderly patients and Iomab-B used to condition the bone marrow of patients. Actinium Pharmaceuticals, Inc. is based in New York.
The stock traded between $0.330 and $0.870 over 1-Year time period showing its price to sales ratio of 0. Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-17.3 and 200-Day Simple Moving Average of $3.15. Its Price to Free Cash Flow is 0 and Price to Book of 3.63.
Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Actinium Pharmaceuticals, Inc. (NYSE:ATNM) reported its Actual EPS of $-0.04/share. The analysts offering Earnings Estimates for the company were believing that Actinium Pharmaceuticals, Inc. could bring EPS of $-0.07/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 42.9 Percent.
AMTEK, Inc. (NYSE:AME)
In the last trading session, AMTEK, Inc. (NYSE:AME) added its value by -0.36% closing at the price of $74.97. The stock currently has market capitalization of 17.15 Billion, with average volume of 1.32 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently AMTEK, Inc. (NYSE:AME) is showing beta of 1.31. This particular value of beta suggests that AMTEK, Inc. (NYSE:AME) has historically moved 131% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for AMTEK, Inc. (NYSE:AME) is at $3.06.
The stock currently has RSI of 58.16. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical devices. AMETEK’s Corporate Growth Plan is founded on four key strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion, and New Products. AMETEK consists of two business groups Electronic Instruments and Electromechanical Electronic Instruments is leader in the design and manufacture of advanced instruments for the process aerospace power and industrial markets Electromechanical is differentiated supplier of electrical interconnects precision motion control solutions specialty metals thermal management systems and floor care and specialty motors. EIG is global leader in process and analytical instrumentation for the oil gas chemical/petrochemical pharmaceutical semiconductor and factory automation markets. EMG is leader in highly engineered electrical connectors and packaging for protecting sensitive devices in aerospace defense medical and industrial applications.
AMTEK, Inc. (NYSE:AME) topped its 52-week high price of $81.92 on 09/21/18 and 52-Week Low Price of $64.91 on 10/29/18. The Stock currently has P/E (price to earnings ttm) of 24.49 and Weekly volatility of 1.93% and monthly volatility of 2.44% respectively.